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Summary 
Interleukin (IL)-7 is a potent stimulus for immature T and B cells and, to a lesser extent, mature 
T ceils. We have inactivated the Ib7 gene in the mouse germline by using gene-targeting tech- 
niques to further understand the biology of IL-7. Mutant mice were highly lymphopenic in the 
peripheral blood and lymphoid organs. Bone marrow B lymphopoiesis was blocked at the transi- 
tion from pro-B to pre-B cells. Thymic cellularity was reduced 20-fold, but retained normal 
distribution of CD4 and CD8. Splenic T cellularity was reduced 10-fold. Splenic B cells, also 
reduced in number, showed an abnormal population of immature B cells in adult animals. The 
remaining splenic populations of lymphocytes showed normal responsiveness  to mitogenie stimuli. 
These data show that proper T and B cell development is dependent on Ib7. The IL-7-deficient 
mice are the first example of single cytokine-deficient  mice that exhibit severe lymphoid abnor- 
malities. 
T 
he biological  activities  of cytokines,  as  measured  by 
in vitro assays, had long suggested that these molecules 
would be important for the development and function of  lym- 
phocytes in vivo. However, gene inactivation studies of many 
of these molecules showed that they were dispensable for the 
development and normal expansion of lymphocytes. Normal 
numbers of T and B cells were found in mice that contained 
induced null mutations of I1.-2 (1), IL-4 (2), I1.-6 (3) (Dal- 
rymple, S. A., L. A. Lucian, R. Slattery, T. McNeil, D. M. 
Aud,  S. Fuchino,  F. Lee, and R. Murray, manuscript sub- 
mitted for publication),  Ibl0 (4), IFN receptors (5), and the 
common receptor for GM-CSF and II.-5 (5a). While all of 
these animals showed varying phenotypes related to the im- 
mune system, the absence of severe  lymphoid developmental 
defects was potentially explained by the redundancy of regula- 
tory cytokine signals. Redundancy implies that removal of 
a single cytokine signal would not be sufficient to inhibit 
or severely alter lymphoid development.  Alternatively, the 
idea of redundant function may have arisen simply because 
the cytokine(s) most crucial for lymphoid development and 
expansion has not yet been examined  by gene-targeting criteria. 
To investigate this issue in more detail, we have disrupted 
the I1.-7 gene in mice by standard techniques. Numerous in 
vitro biological activities of IL-7 have suggested some unique 
features of this molecule. For example, the stimulation of lym- 
phocytes by IL-7 appears to be more restricted to immature 
populations (6, 7) compared with many other cytokines, and 
IL-7 does not always require additional costimulatory agents 
(8). Proliferation of early B cells in bone marrow stromal 
cultures seemed to be dependent on the presence of IL-7 (9). 
I1.-7 was also shown to be a maintenance and survival factor 
for thymocytes (10), an activity unique to this cytokine. Ad- 
ditionally, antibody neutralization experiments predicted that 
Ib7 plays an important role in B and T cell development in 
vivo (11, 12). 
The receptors for IL-7 include, at minimum, two subunits, 
the IL-7Rol chain and the IL-2R'y chain (also referred to as 
the common y  chain)  (13-16). As is the case with most 
cytokine-receptor interactions, these two receptor subunits 
also bind several other ligands. The IL-2R3, chain is neces- 
sary for IL-7 binding as well as for IL-2 (17), IL-4 (18, 19), 
I1.-9 (20), and II.-15 binding (21). Another subunit, IL-7Rot, 
binds II.-7 and at least one additional cytokine, thymic stromal 
derived lymphopoietin (TSLP)  1 (22). The Ib2R3, chain has 
been shown to be deficient in human X-linked severe com- 
bined immunodeficiency (XSCID), which results in profound 
effects on human lymphoid development and function (14). 
Gene inactivation studies of common receptor subunits are 
likely to result in cumulative phenotypes. Therefore, in these 
types of experiments, it is impossible to discern which aspects 
1 Abbreviations used in this paper: ES, embryonic  stem; HSA, human  serum 
albumin; HSVtk, herpes  simplex  virus  thymidine  kinase  gene;  TSLP, thymic 
stromal-derived  lymphopoietin;  WBC, white  blood  cell; XSCID, X-linked 
severe combined  immunodeficiency. 
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cytokine. Cytokine-deficient mice are necessary for under- 
standing the basic role of  ligand molecules, for understanding 
the potential redundancies in the cytokine network, and for 
providing the framework on which to interpret potentially 
more  complex  phenotypes  associated  with  mice  lacking 
common receptor subunits. 
We reasoned that the targeted disruption of Ib7 would 
allow us to address whether this single cytokine, due to its 
potentially unique activities, would approximate an XSCID- 
like  phenotype,  or  whether  the  collective  elimination of 
numerous cytokines that interact with the common IL-2Ry 
chain, or other receptor systems, would be necessary to pro- 
duce severe effects on the development and expansion of lym- 
phocytes. 
Materials and Methods 
Gene Targeting.  An IL-7  gene-targeting vector was constructed 
using a vector containing a Neomycin  resistance gene (neo) flanked 
by multiple cloning sites. At the 3' end, a herpes simplex virus 
thymidine kinase gene (HSVtk) was positioned to permit negative 
selection against random integration.  Both resistance genes are 
driven by an HSVtk promoter. Cells of the embryonic stem (ES) 
cell line E14.1 were transfected  with linearized  vector by electropo- 
ration. Culturing was done in DMEM with 15% FCS with 2,500 
U/ml recombinant leukemia  inhibitory factor (ESGRO  TM, GIBCO 
BRL, Gaithersburg, MD) on a layer of Mitomycin C-treated pri- 
mary embryonic  fibroblasts. The cells were selected  with G418 (350 
#g/m1) and Gancyclovir  (2 #M). Surviving clones were screened 
by Southern blot for homologous recombination. The mutated 
clones were injected into blastocysts  from C57BL/6 mice and im- 
planted into pseudopregnant B6xCBA F1 females. The resulting 
male chimeras were mated to C57BL/6 females to test for germ- 
line transmission.  Offspring derived  from the ES cells were identified 
by coat color and tested by Southern blot analysis  for the presence 
of the mutation.  Heterozygous animals were crossed to obtain 
homozygous mutant animals. 
Molecular Analysis of lL 7 Deletion.  Total  RNA was extracted 
from thymic stromal cells in RNAzol. Reverse-transcriptase  PCR 
reactions were performed (Perkin-Elmer Corp.,  Norwalk,  CT; 
Boehringer Mannheim Corp.,  Indianapolis, IN) (primers: sense 
5'-GGAATTCCTCCACTGATCCT-Y,  Antisense  5'-CTCTCAGTA- 
GTCTCTTTAGG-3'), and the specificity  of the PCR bands was 
confirmed  by transfer to Nytran (Schleicher  & Schuell, Inc., Keene, 
NH) and hybridizing the filter with an 1I.-7 eDNA probe. 
Gross Characterization and Blood Counts.  All experiments were 
done on F2 animals, derived from heterozygous parents, aged 5-8 
wk unless otherwise noted. The white blood cell (WBC) counts 
were done using an automated cell counter (Sereno-Baker Diag- 
nostics Inc., Allentown, PA). For differential  counts, blood smears 
were stained  with Wright-Giemsa  stain and counted under the light 
microscope. Results are expressed as the mean of at least seven 
samples  _+  SD. 
FAGS |  Analysis.  Cell populations were isolated from bone 
marrow, thymus,  and spleen. 106 cells were stained in 96-well 
plates for 30 min on ice. The PE-conjugated mAbs were directed 
against CD43 ($7), CDS, and TCR-ot~. FITC-conjugated mAbs 
were directed against CD3 and IgM  b.  Biotin-conjugated mAb 
directed against CD24 (human serum albumin, HSA) was obtained 
from PharMingen (San Diego, CA) as well. The mAb against mouse 
IgD was obtained from Southern Biotechnology Associates (Bir- 
mingham, AL). Tricolor conjugated mAbs directed against CD4 
and B220 were obtained from CALTAG  Labs (South San Francisco, 
CA). The avidin-Texas red conjugate was obtained from Leinco 
Technologies Inc. (Ballwin,  MO). Cell surface immunofluorescence 
analysis  was performed  by use of a cell  sorter (Vantage; Becton  Dick- 
inson Immunocytometry Systems, San Jose, CA). 
Proliferation Assay.  Splenocytes  and thymocytes were isolated 
aseptically and depleted of erythrocytes by osmotic shock. Cells 
were cultured at 10  s cells/well in 96-well plates in RPMI with 
10% FCS and supplements. The splenocytes  were stimulated with 
50/~g/ml LPS or 50 #g/ml Con A for 2 d. Thymocytes  were stimu- 
lated with 2.5/~g/ml Con A with 20 ng/ml Ib2 for 3 d. Cells 
were pulsed with 0.5 /~Ci [3H]thymidine for 12  h before har- 
vesting, and [3H]thymidine incorporation was measured. 
Results 
Generation oflL-7-/-  Mice.  The IL-7 targeting vector 
was constructed by use of genomic DNA isolated from a 
genomic  DNA  phage  library  made  from  129/SV  mice 
(Stratagene Inc., LaJoUa, CA) in order to maximize homology 
between the targeting plasmid and the I1.-7 locus. Two 2.3- 
kb fragments were cloned 5' and 3' of the neo gene (Fig. 
1 A). Homologous recombination would create a complete 
deletion of exon 4 (28.3% of coding sequence) and 300 bp 
of flanking sequence. DNA from resistant ES colonies was 
digested with BamHI and XbaI  and Southern blots were 
probed with a 3.1-kb  external probe located 3' of the tar- 
geting sequences (Fig. 1 B). Hybridization with a neo gene 
probe was performed to ensure a single integration site (data 
not shown). The frequency of homologous recombination 
was I out of 1,166 doubly resistant clones. Appropriately tar- 
geted ES cells were injected into C57BL/6 blastocysts.  IL- 
7-/-  mice were generated from matings between I1.-7  +/- 
mice at the expected  Mendelian frequency. 
To evaluate the inactivation of the IL-7 gene we performed 
reverse-transcriptase PCR analysis of thymic stromal cell RNA 
from 2-wk-old mice, using primers at the 5' and 3' end of 
the eDNA. Hybridization with the eDNA showed that there 
was no appropriate specific II.-7 message found in IL-7-/- 
animals (Fig. 1 C). B-actin PCK showed equivalent amounts 
of KNA in each sample (data not shown). The induced mu- 
tation was designed to remove two of four o~-helical  bundles 
of the cytokine structure, but also resulted in apparent mKNA 
instability. Attempts to culture thymic stromal cells to de- 
tect Ib7 biological activity were unsuccessful from both IL- 
7-/-  and IL-7+/+  mice. 
Macroscopic Analysis of  lL T- /-  Mice.  ThelL-7-/- mice 
appeared healthy at birth and developed normally. Both sexes 
were fertile. In the mutant mice, the thymus and the spleen 
were reduced in size and weight, and lymph nodes or Peyer's 
patches were not detected. Histologically, the thymus of the 
IL-7-/-  mice showed cortical and medullary areas and the 
spleen showed a normal structure with red and white pulp 
(data  not shown). 
IL 7-/-  Mice Exhibited Severe Pe@heral Blood and Tissue 
Lymphopenia.  Ib7-mutant animals were tail bled and ex- 
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(.4) The I1:7 gene locus is shown with 
restriction enzyme sites: B, BamHl; E, 
EcoRI; X, XbaI. Exons are represented 
as  black  boxes. The  gene-targeting 
vector contains  two 2.3-kb  fragments 
of the I1:7 gene as shown. Exon 4 and 
300 bp  of the flanking  introns  were 
replaced with the neo gene. The vector 
was  linearized  with  ClaI,  C,  before 
transfection. The predicted structure of 
the targeted locus is shown,  with the 
length of diagnostic  restriction  frag- 
ments and location of probe sequences 
used  for  Southern  blot  analysis.  (B) 
Southern blot analysis ofE14.1 parental 
cells, an appropriately targeted ES clone, 
and tail DNA from F2 offspring derived 
from heterozygous  parents  is shown. 
DNA was digested with BamHI and 
XbaI  and  hybridized  with  the probe 
shown  in  Fig.  1  A.  (C)  Reverse- 
transcriptase  PCR of thymus stromal 
RNA  from  2-wk-old  mice.  The 
thymuses  from  Ib7-/-  mice  were 
much smaller than those from control 
animals. Equivalent amounts of RNA 
from mutant mice are likely to repre- 
sent an enrichment of the stromal cell 
type known to produce 11:7. The PCR 
was performed with primers located at 
the 5' and 3' end of the cDNA. The 
blot was hybridized with 11:7 cDNA. 
amined for peripheral  WBC counts. Animals were grouped 
from 5 wk to 14 wk. Fig. 2 A  shows a significant decrease 
in WBC counts in the mutant animals irrespective  of their 
age.  All  other  blood  parameters  such  as  red blood  cells, 
platelets, hemoglobin, and hematocrit were in normal ranges. 
These same samples were used to produce blood smears, and 
were evaluated for cell types. The reduced WBC in the mu- 
tant animals was due to a severe reduction of lymphocytes 
from an average of 68.2% to 9.5% (Fig. 2 B). The nonlym- 
phoid cells in these smears gave normal ratios and absolute 
numbers of monocytes and granulocytes. 
The bone marrow, thymus, and spleen were then evalu- 
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Figure 2.  WBC analysis in liT7-/- and 
IbT+/+  control mice. (A) WBC counts 
in  5-14-wk-old  II:7-/-  and  I1:7+/+ 
control mice. (B) Differential blood count 
of the same blood samples of Fig.  2 A. 
The data represent  mean  _+  SD values of 
experiments  of 17 11:7-/-  mice and  12 
control mice. 
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Figure  3.  Analysis  of  lym- 
phoid cellularity in Ib7-/-  and 
II-7+/+ control mice. Total cell 
numbers  of spleen, thymus,  and 
bone marrow (collected from two 
femurs) from mice aged 5-7 wk. 
The data represent  mean  _+  SD 
values of experiments  with nine 
IF7-/-  mice and seven control 
mice. 
ated for cellularity. While Ib7 mutants had normal numbers 
of bone marrow cells, both thymus and spleen cellularities 
were reduced to <5 and 15% of controls, respectively (Fig. 3). 
Collectively, these data show a strong dependence on IL-7 
for proper expansion of lymphoid lineages.  The lymphopenic 
state persisted in mice up to 4 mo of age,  and to date,  has 
shown no increase of peripheral lymphocytes. Additionally, 
this  stable  phenotype  has  shown  little  animal-to-animal 
variation. 
B Lymphopoiesis in the Bone Marrow Was Blocked at the Tran- 
sition to Pre-B Cells.  Hardy et al. (23) have characterized rou- 
tine B lymphopoiesis by a series  of developmentally regu- 
lated cell surface molecules. B cells are classified from most 
immature (fraction A) to increasingly more mature popula- 
tions (fractions B-F) using cell surface markers such as B220, 
IgM, $7, and HSA. We used these general criteria to evaluate 
the bone marrow development of B cells in the Ib7-mutant 
mice. Fig. 4 A  shows that the mutant animals  contained al- 
most  no  B220+/IgM + bone marrow  cells,  in  contrast  to 
control animals.  As these cells represent later stages orb lym- 
phopoiesis  in  the bone  marrow,  we used four-color flow 
cytometry to evaluate  the more immature populations con- 
tained  within  the  B220+/IgM -  fraction.  Fig.  4 B  shows 
that, when gated on B220+/IgM -  cells, the population of 
B220 +/IgM-/$7-/HSA + cells was not present, indicating 
that the transition of fractions B and C to fraction D in mu- 
tant animals was blocked. Thus, the transition to the pre-B 
cell population  (fraction D) was severely  impaired. 
Reduced Thymocyte Numbers Exhibited Normal Composition 
of Thymic Subsets.  The remaining 5% ofthymocytes in the 
mutant  animals were examined for CD4,  CDS,  and CD3 
expression.  Fig. 5 shows that the thymic subpopulations were 
present in normal ratios, and suggests that proliferation and 
expansion  rather  than  differentiation  were affected by the 
lack of I1-,7. A minor observation, which was consistent in 
all  mice tested,  was a slight  increase in  the percentage  of 
CD4 +/CD8 + cells in the IL-7-/-  animals. 
Analysis of Splenic Abnormalities in IL7-/-  Mice.  The 
spleens of mutant animals exhibited a reduction in cellularity 
(Fig.  3). As splenocytes represent a collection of cell types, 
we evaluated the absolute numbers of lymphocytes in this 
tissue. Based on FACS  |  staining,  we found a severe reduc- 
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Figure 4.  Immunofluorescent analysis of bone marrow 
from  IL-7-/-  and  Ib7+/+  control  mice.  (A)  Bone 
marrow stained with FITC-anti-IgM and tricolor-anti- 
B220 gated  on lymphocytes.  (B) Bone marrow stained 
with PE-antbS7 and biotinylated  anti-HSA  followed by 
streptavidin-Texas red gated on IgM-/B220 + cells (square 
in Fig. 4 A). The boxes indicate B call fractions A-D. The 
data are results of a representative  experiment. 
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Figure 5.  Immunofluorescent analysis of thymocytes 
from IL-7-/-  and IbT+/+ control mice. (.4) Thymus 
cells stained with PE-anti-CD8 and tricolor-anti-CD4 
gated on lymphocytes.  The percentage  of cells in each  quad- 
rant is indicated. (B) Thymus  ceUs  stained  with FITC-anti- 
CD3 gated on lymphoeytes.  The data are results of a rep- 
resentative experiment. 
tion in absolute numbers of mature splenic B and T cells (Fig. 
6 A). In addition,  the relative proportion of B cells was re- 
duced within the spleens of Ib7-defident mice (Fig. 6 B). 
Three-color FACS  |  analysis  of spleen cells was performed 
to determine the phenotype of the remaining lymphocytes. 
A population of B220 §  + mature B cells were present, 
and at least  some of these cells were IgD +,  although  at a 
lower percentage than in controls (Fig. 7, A  and B). In addi- 
tion, a population of B220 +/IgM-  cells existed in the mu- 
tant animals,  which was not found in the control animals, 
suggesting a significant number of immature B ceUs in the 
adult spleen. Analysis of the remaining splenic T  cell popu- 
lations showed normal staining patterns of CD4, CD8, and 
CD3  (data  not  shown). 
Thymocyte and Splenocyte Response to Mitogenic Stimuli.  As 
the IL-7-mutant animals displayed reduced but stable numbers 
of splenic lymphocytes and thymocytes, we evaluated the re- 
sponse of these cells to LPS, Con A, or Con A  plus rIL-2. 
The B cell response to LPS was reduced if total splenocytes 
were used. However, as the spleen showed reduced numbers 
of B cells as well as an additional reduction in the ratio of 
B  (B220+/IgM +)  to non-B  ceils,  we normalized  the per- 
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Figure 6.  Analysis of lymphoid cellularity in the spleen. 
(A) Absolute cell number orb cells and T cells in the spleen. 
The numbers are based on FACS  ~ staining with B220 and 
IgM or TCR-~x3. The data represent mean _+ SD values of 
experiments with four IbT-/- mice  and four control mice. 
(B)  Relative percentage of B cells and  T  cells in  total 
splenocytes. 
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Table 1.  Thymocyte and Splenocyte Response to Mitogenic Stimuli 
A.  Proliferation of splenic B  cells 
Uncorrected cell numbers  Corrected  cell numbers 
Unstimulated  LPS  Unstimulated  LPS 
IL7  +/+  120  •  13  143,804  _+  12,321  120  143,804 
IL7  -/-  115  •  26  56,766  +_  8,386  367  181,083 
B.  Proliferation of splenic T  cells 
Unstimulated  Con A 
IL7  +/+  330  +  61  8,975  _+  1,639 
IL7  -/-  367  _+  22  8,296  _+  2,043 
C.  Proliferation of thymocytes 
Unstimulated  Con A + IL2 
IL7  +/+  122  +  32  116,766  -+  21,008 
IL7  -/-  96  _+  9  161,396  -+  11,655 
Splenic B or T cells and thymocytes were examined for proliferative responses to the indicated stimuli. Results of a representative experiment  are 
shown with average cpm  •  SD of triplicate wells. 
1524  Lymphopenia in Interleukin 7 Gene-deleted  Mice centage shown in Fig. 6/~ Table 1 A  shows that the prolifer- 
ative response of B cells  was similar  to controls when the 
cell population  was normalized.  T  cells in the spleen also 
gave reduced overall numbers of cells, but a normal ratio of 
T  to non-T cells, so no correction factor was necessary,  and 
Table 1 B shows that the Con A response of splenic T cells 
was normal. Similarly,  the response of the remaining thymo- 
cytes to Con A  plus rlL-2  was similar for both groups  of 
animals  (Table  1 C). 
Discussion 
Gene targeting  analysis  of cytokine molecules has led to 
a better understanding of the role of these molecules during 
immune  responses  and  normal  regulation  of the immune 
system. However, a consistent fnding in the cytokine gene 
disruption literature has been the absence of severe lymphoid 
defects due to inactivation  of a single cytokine gene.  One 
collective interpretation of these experiments would suggest 
that  the normal  appearance and expansion of lymphocytes 
is not critically dependent on any individual cytokine. An- 
other possibility is that cytokines playing a more crucial role 
in the appearance and expansion of lymphocytes may be as 
yet uncharacterized,  or not yet analyzed by gene-targeting 
experiments. 
The data we have presented in this report would favor the 
latter of these two possibilities. This report identifies  the first 
single-cytokine gene-defident mouse that exhibits severe lym- 
phoid abnormalities. Inactivation of the IL-7 gene has shown 
a stable phenotype of severe peripheral blood lymphopenia. 
This defect can be traced back to abnormal B lymphopoiesis 
in the bone marrow. The transition between pro-B, fractions 
B/C  (B220+/IgM-/S7+/HSA +)  and  pre-B,  fraction  D 
(B220 +/IgM-/$7-/HSA +) was blocked. According to the 
B cell development scheme suggested by Hardy et al.  (23), 
fractions B and C show a strong proliferative  response to IL-7, 
whereas fraction D is unresponsive to IL-7. Our data indicate 
that the proliferative response of cells in fractions B and C 
to IL-7 is not due to IL-7 exclusively. However, the differenti- 
ation of fraction B/C to fraction D  showed an absolute de- 
pendence on IL-7. The peripheral lymphopenia can also be 
traced to inefficient thymic development where only 5% of 
normal thymocyte numbers exist. However, the relative ratios 
of thymic  subpopulations  were  normal,  and  only  overall 
numbers of cells were reduced. This is consistent with IL-7 
being described in vitro as a proliferation and maintenance 
factor for thymocytes, but not as a differentiation factor (10, 
24,  25). 
Further analyses revealed  an interesting phenotype of the 
few remaining lymphocytes. In addition to reduced numbers 
of B220+/IgM + cells,  there was a population  of B220+/ 
IgM-  cells,  which was not present in control mice. These 
cells may represent premature migration of B cells from bone 
marrow to spleen, or alternatively, abnormal splenic B lym- 
phopoiesis.  The remaining B220 +/IgM + cells in the mutant 
animals contained surface IgD + cells, but in lower numbers 
and percentages.  T  cell populations in the spleen were also 
reduced in number, but normal population  of cells as ana- 
lyzed by CD4,  CDS,  and CD3 were present. 
It is useful to compare the phenotype of the mice we de- 
scribe here to the recent report of IL-7Rol -/-  mice (22). 
IL-7Rol -/-  mice exhibited a similar overall reduction of B 
cens, but showed a block in B cell development at the transi- 
tion of pre-pro-B cells  (fraction A) to pro-B cells (fraction 
B). The Ib7-/-  mice were inhibited in the transition from 
B/C to D, which represents a later developmental block. This 
difference is likely to be due to other cytokines that use the 
Ib7Rc~ chain, such as TSLP. Paradoxically,  treatment of mice 
with anti-IL-7 antibodies does not fit precisely with this idea 
(11). Instead of showing the predicted block equivalent  to 
Ib7-deficient  mice,  antibody-treated  mice  appeared  to be 
blocked at a stage similar to the Ib7Ro~-/-  mice. Perhaps 
the antibody treatment  is affecting other cytokines that in- 
teract through the IL-7Rc~ chain, as it is difficult to imagine 
that IL-7 neutralization by an antibody could result in a pheno- 
type more severe than  in the corresponding  gene inactiva- 
tion  study presented here. 
In  contrast  to  the  stable  reduction  of thymocytes  we 
reported, Ib7Rcr -/-  mice inexplicably showed two different 
phenotypes in thymic development. One was similar to the 
IL-7-/-  mice and the other was more severe. Although the 
reason for the variability is unclear,  the more severe pheno- 
type is again likely due to other molecules interacting through 
the Ib7Rc~ chain. 
The IL-7-/-  mice exhibited similar lymphocyte abnor- 
malities  to  IL-2R3/-deficient  mice  (26),  even  though  this 
receptor subunit is shared by at least four other cytokines. 
Neither the gene inactivation of IL-2 (1) or II:4 (2), or the 
double mutation  of IL-2 and IL-4 (27)  showed any defects 
in lymphopoiesis. This indicates that most of the lympho- 
cyte developmental abnormalities seen in an IIr 
model of murine XSCID  are due mainly to IL-7,  and not 
other cytokines that  bind to IL-2R'y. 
The data shown here indicate that  Ib7 is a unique and 
nonredundant cytokine, in that it is essential for normal lym- 
phocyte development. To date, II:7-deficient mice have demon- 
strated the most profound effect on lymphoid development 
in contrast to gene inactivation of other cytokines previously 
thought  to be important  for lymphocyte development. 
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